共 191 条
[1]
Agarwal K(2020)Therapeutic options in vitiligo with special emphasis on immunomodulators: a comprehensive update with review of literature Dermatol Ther 33 e13215-39
[2]
Podder I(2021)Family vitiligo impact scale: a scale to measure the quality-of-life of family members of patients with vitiligo Indian J Dermatol Venereol Leprol 88 32-2283
[3]
Kassir M(2018)Identifying key components for a psychological intervention for people with vitiligo—a quantitative and qualitative study in the United Kingdom using web-based questionnaires of people with vitiligo and healthcare professionals J Eur Acad Dermatol Venereol 32 2275-614
[4]
Agrawal S(2016)Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades Int J Dermatol 55 608-81
[5]
Satapathy S(2013)Cumulative life course impairment: identifying patients at risk Curr Probl Dermatol 44 74-106
[6]
Gupta V(2008)Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire Dermatology 217 101-88
[7]
Ahmed A(1996)Tyrosinase as an autoantigen in patients with vitiligo Clin Exp Immunol 105 84-537
[8]
Steed L(2020)Korean society of vitiligo evaluation for skin cancer and precancer in patients with vitiligo treated with long-term narrowband UVB phototherapy JAMA Dermatol 156 529-56
[9]
Burden-Teh E(1972)400 cases of vitiligo. A clinico-therapeutic analysis Indian J Dermatol 17 51-270
[10]
Amer AA(2021)Vitiligo: a focus on pathogenesis and its therapeutic implications J Dermatol 48 252-592